Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 75 clinical trials
Safety and Efficacy of TAF to Prevent MTCT of HBV in Middle/Late Pregnancies With High HBV DNA Load

Study of Liver Diseases (AASLD) and European Association for the Study of Liver Diseases (EASL) recommend that pregnant women with high HBV DNA load should take anti-hepatitis B viral drugs (tenofovir

mother-to-child transmission
fumarate
hepatitis
tenofovir
prenatal
  • 0 views
  • 04 Oct, 2022
  • 1 location
Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents

Tenofovir (TFV) disoproxil fumarate (TDF) plus emtricitabine (FTC) or lamivudine (3TC) is the preferred nucleoside backbone of first-line antiretroviral therapy (ART) for adolescents in sub

antiretroviral agents
HIV Infection
antiretroviral therapy
lamivudine
HIV Vaccine
  • 0 views
  • 27 Jun, 2022
  • 1 location
MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence Among HIV+ Prescription Opioid Users (MyTPill)

This study compares several different antiretroviral adherence measures, including digital pills, in HIV+ individuals who are maintained on opioid analgesics.

  • 0 views
  • 18 Oct, 2022
  • 1 location
Clinical Characteristics, Natural Outcome and Treatment Optimization of Refractory

Refractory hepatitis B is to point to although standard application nucleoside (acid) analogue treatment undertakes primary treatment and two strengthen treatment, but existence is persistent viremia. Currently, there is no consensus on salvage therapy for patients who remain virus-positive after a second round of antiviral therapy. This is the first …

antiviral drugs
  • 0 views
  • 29 May, 2022
  • 13 locations
Bictegravir in the Elderly Living With HIV (BICEP)

This is a prospective, open-label, single center, post-approval and post-marketing study. Current national guideline recommends an integrase strand inhibitors (INSTI) in combination with two nucleoside reverse transcriptase inhibitors (NRTIs) as standard of therapy for HIV-1 infected patients. INSTI-based regimen may require a potent CYP3A inhibitor such as cobicistat to increase …

  • 0 views
  • 06 Oct, 2021
  • 1 location